Thursday, June 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

D-Wave Quantum: Bridging the Atlantic With a $550M Acquisition and a London Debut

Jackson Burston by Jackson Burston
June 11, 2026
in AI & Quantum Computing, Mergers & Acquisitions, Tech & Software
0
D-Wave Quantum Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

D-Wave Quantum is no longer content to be just a North American story. In a span of months, the company has moved its headquarters to Florida, bought a gate-model specialist for half a billion dollars, and scheduled a flagship user conference in London for June 18. The message is clear: quantum computing is leaving the laboratory, and D-Wave intends to be the platform that carries it into the commercial mainstream.

The January acquisition of Quantum Circuits Inc. (QCI) for $550 million was the biggest single statement of intent. D-Wave paid $250 million in cash and the rest in stock, folding QCI’s error-corrected gate-model technology into its existing annealing systems. The result is a dual-platform architecture that covers everything from near-term logistics optimisation to long-term scientific simulation — a breadth few rivals can match.

From California to Boca Raton

The company is also voting with its feet. D-Wave is relocating its headquarters from California to Boca Raton, Florida, and has signed a $20 million deal with Florida Atlantic University to install an Advantage2 system on campus. The partnership will create a regional quantum centre for workforce training and applied research, particularly around logistics and supply-chain problems.

That geographic shift dovetails with a push into Europe. The London conference, dubbed “Qubits Europe 2026: Quantum Realized,” will feature live demonstrations and case studies from customers and government agencies already using D-Wave systems. The timing is deliberate: Britain has been stepping up its quantum ambitions, and King Charles III specifically cited quantum computing in his April address to the U.S. Congress as a technology that will shape future UK-US relations. Europe has not been a core market for D-Wave until now — that is changing.

Bookings explode, but dilution bites

The first-quarter numbers underscore the momentum. Booking volume surged nearly 2,000% year-over-year, and remaining performance obligations — the contracted revenue backlog — jumped 563%. D-Wave now expects to close two to three system sales per year, up from a prior estimate of one. A recent $10 million deal with an unnamed Fortune 100 company, spanning two years of quantum services, shows that large enterprises are moving from pilots into production.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Yet the share count is a growing concern. The diluted share count climbed to roughly 367 million by May 2026, compared with around 286 million a year earlier. That dilution is a risk that several analysts have highlighted, even as they maintain a bullish stance on the underlying business.

Stock recovers from spring lows, still far from peak

After a turbulent start to the year, D-Wave’s shares found a floor in March at €11.12 – a 52-week low. The subsequent recovery has been sharp: the stock now trades at €20.67 (€20.69 in recent sessions), a gain of nearly 86% from that trough. But it remains well below the October 2025 record high of €38.48.

Technically, the shares are testing important levels. The 50-day moving average sits at €18.57, while the 200-day average is just above at €20.85. With the stock hovering right around that longer-term line, the London conference could provide a catalyst for a decisive breakout. The relative strength index of 48.5 points to a healthy consolidation rather than overbought conditions.

Analysts see upside, but execution is key

The Street remains broadly optimistic. A survey of 15 analysts by S&P Global carries a “Strong Buy” consensus, with an average price target of $36.44. A separate poll cited in European reports puts the target at €31.59. Stifel recently reiterated a buy rating with a $35 price target. All told, the implied upside from current levels is roughly 50% or more.

But the market capitalisation of €7.66 billion prices in a lot of future growth for a company that is not yet profitable. The dual-platform strategy, the Florida-FAU partnership, and the London roadshow are all designed to accelerate revenue. Whether the company can deliver dependable recurring income from those high-profile relationships will determine if the stock can climb back toward its old highs — or if the dilution and volatility will keep it anchored.

Ad

D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from June 11 delivers the answer:

The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 11.

D-Wave Quantum: Buy or sell? Read more here...

Tags: D-Wave Quantum
Jackson Burston

Jackson Burston

Related Posts

Diginex Stock
Crypto Stocks

Diginex’s $1.5 Billion Goliath Gamble: A Penny Stock’s Fight for Survival and Nasdaq Listing

June 11, 2026
Palantir Stock
AI & Quantum Computing

Palantir’s Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization

June 11, 2026
Alphabet Stock
AI & Quantum Computing

Alphabet’s $80 Billion Capital Raise Backs a $35 Billion Anthropic Wager Amid Legal and Operational Challenges

June 11, 2026
Next Post
Alphabet Stock

Alphabet's $80 Billion Capital Raise Backs a $35 Billion Anthropic Wager Amid Legal and Operational Challenges

Asml Stock

ASML's Social Pact Turns Redundancy Into Reassignment as Shares Flirt With Record

Ocugen Stock

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

Recommended

Technology Quantum computing Stock Exchange

ScanSource Inc Reports Disappointing Financial Results and Downward Sales Forecast

2 years ago
Albemarle Stock

Albemarle Stock: Surprise Profit Sparks 6% Rally

11 months ago
Seacor Marine Stock

Legal Setback Compounds Challenges for Offshore Services Provider

9 months ago
ASML Stock

Mixed Messages for ASML Investors

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

ASML’s Social Pact Turns Redundancy Into Reassignment as Shares Flirt With Record

Alphabet’s $80 Billion Capital Raise Backs a $35 Billion Anthropic Wager Amid Legal and Operational Challenges

D-Wave Quantum: Bridging the Atlantic With a $550M Acquisition and a London Debut

Plug Power’s Two-Pronged Rescue: Asset Sales and a Dilution Vote Collide Amid a 20% Rout

BYD’s Dash for Global Supremacy Encounters Pentagon Hurdles and Home Market Headwinds

Trending

Diginex Stock
Crypto Stocks

Diginex’s $1.5 Billion Goliath Gamble: A Penny Stock’s Fight for Survival and Nasdaq Listing

by Kennethcix
June 11, 2026
0

The clock is ticking for Diginex. With the deadline for a transformative $1.5 billion acquisition expiring on...

Palantir Stock

Palantir’s Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization

June 11, 2026
Heidelberger Druckmaschinen Stock

Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain

June 11, 2026
Ocugen Stock

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

June 11, 2026
Asml Stock

ASML’s Social Pact Turns Redundancy Into Reassignment as Shares Flirt With Record

June 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Diginex’s $1.5 Billion Goliath Gamble: A Penny Stock’s Fight for Survival and Nasdaq Listing
  • Palantir’s Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization
  • Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com